Vermilion Life Sciences Ltd
Stuart is Chair of the Advisory Committee on Clinical Excellence Awards (ACCEA). He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years’ experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine, Takeda and UCB. He is the Founder of Vermilion Life Sciences, which provides consultancy services to reduce the time and cost of medicines development to improve patient access.
Stuart is also an Authority Member of the Human Tissue Authority, a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion'' for the UK Government''s Office for Life Sciences, Accelerated Access Review.
Reengineering Medicines Development
Exploring opportunities to reduce the cost and time of medicines development. How patient input, digital tools and real world data in real time can facilitate adaptive licensing and early regulator and payer discussions to generate early access.
EVEN MORE SEMINARS
Luca Boldrini Università Cattolica del Sacro Cuore, Roma, Italia
Radiomics applications rectal cancer: the MRIdian perspective
Clare Hutton & Peter Colley Hull & East Yorkshire Hospitals NHS Trust
The Implementation & Development of IMRT in Hull
Hamed Javan MD Jewish General Hospital
Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer
Dr Nathan Hill MedInfomatics Ltd
Electronic Medical Records – have they lived up to expectations?
Jamie Rae Throat Cancer Foundation
The Throat Cancer Foundation; how we changed a government’s mind